USPTO issues patent for Rosetta Genomics’ human microRNA miR-193b (News-Medical-Net)
Filed in Mesothelioma News on Nov.06, 2009
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No
Read the whole story here:
USPTO issues patent for Rosetta Genomics’ human microRNA miR-193b (News-Medical-Net)

Leave a Reply
You must be logged in to post a comment.